1Poster Specifications
Orientation: Vertical (portrait)
Size: A0 (84.1 cm × 118.9 cm) or 1080 × 1920 px for screens
Aspect ratio: 9:16
File type: High-resolution PDF, PNG, or JPEG
File size: ≤ 10 MB
2Content Requirements
Title & author names in large, bold font at the top
Full author names, affiliations, and institutional logos included
Poster content matches the approved abstract
Trade names spelled out on first mention only; generic names used thereafter for all drugs/compounds
3Design Recommendations
Font Sizes
Title: 80–100 pt
Section headers: 50–70 pt
Body text: 30–45 pt (minimum 24 pt)
Readability
Legible from 1–2 meters away
Bullet points used; text kept concise
Color & Contrast
High contrast (e.g., dark text on light background)
Limited to 2–3 complementary colors
Red/green combinations avoided (colorblind accessibility)
Graphics
High-resolution charts/images used
All figures clearly labeled
Layout
Sections numbered or arrows used to guide reading (top to bottom)
4Presenter Identification
Photo and short professional bio or email in a corner (top or bottom)
Optional: QR code linking to CV, profile, references, or extended materials
5Submission Deadlines
Final poster upload deadline: November 1st, 2026, 11:59 p.m.
Poster submitted electronically via the designated email
After receiving the acceptance email, abstract submission is allowed until November 22nd at the latest in provided template
6Presentation Logistics
Session time: TBD — group slot notified by November 29, 2026
Presentation time: maximum 2 minutes per participant
Presenter present during assigned time slot
Backup copy of poster prepared in case of technical issues
7Optional Enhancements
Downloadable handouts, extended abstracts, or video summaries via QR code/link
Alt-text added to key images (if hosted on a web platform)